OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment
Anda Shi, Zengli Liu, Zhongqi Fan, et al.
Gut (2024) Vol. 73, Iss. 8, pp. 1350-1363
Closed Access | Times Cited: 9
Anda Shi, Zengli Liu, Zhongqi Fan, et al.
Gut (2024) Vol. 73, Iss. 8, pp. 1350-1363
Closed Access | Times Cited: 9
Showing 9 citing articles:
Mast cells: key players in digestive system tumors and their interactions with immune cells
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
The Crosstalk with CXCL10‐Rich Tumor‐Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape
Hanlin Yin, Qiangda Chen, Shanshan Gao, et al.
Advanced Science (2025)
Open Access
Hanlin Yin, Qiangda Chen, Shanshan Gao, et al.
Advanced Science (2025)
Open Access
EEF1AKMT4-eEF1A2 synergistically facilitates the progression of GBC by promoting ribosomal protein output
Yuncheng Li, Qiang Gao, Yong‐chang Tang, et al.
Genes & Diseases (2025), pp. 101619-101619
Open Access
Yuncheng Li, Qiang Gao, Yong‐chang Tang, et al.
Genes & Diseases (2025), pp. 101619-101619
Open Access
Cisplatin-induced Disruption of Mitochondrial Divisome Leads to Enhanced Cisplatin Resistance in Cholangiocarcinoma
Guoyue Lv, Wentao Mu, Yan‐Nan Cao, et al.
Journal of Hepatology (2025)
Open Access
Guoyue Lv, Wentao Mu, Yan‐Nan Cao, et al.
Journal of Hepatology (2025)
Open Access
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3542-3542
Open Access | Times Cited: 2
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3542-3542
Open Access | Times Cited: 2
Mast cells and histamine in cholangiocarcinoma: exploring overlooked avenues for enhanced patient management
Luca Fabris, Jonathan Pol
Gut (2024) Vol. 73, Iss. 8, pp. 1229-1231
Closed Access | Times Cited: 1
Luca Fabris, Jonathan Pol
Gut (2024) Vol. 73, Iss. 8, pp. 1229-1231
Closed Access | Times Cited: 1
Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies
Huiguang Chen, Xuexin Xu, Jingxian Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Huiguang Chen, Xuexin Xu, Jingxian Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC
Li-xin Du, Guo‐li Sheng, Anda Shi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Li-xin Du, Guo‐li Sheng, Anda Shi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma
Kangshuai Li, Yi Liu, Tingguo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Kangshuai Li, Yi Liu, Tingguo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
